Cargando…

Current controversies in glia-to-neuron conversion therapy in neurodegenerative diseases

Detalles Bibliográficos
Autores principales:	Cao, Peng, Li, Jianan, Liu, Zhuxi, Liang, Guobiao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2023
Materias:	Perspective
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10664116/ https://www.ncbi.nlm.nih.gov/pubmed/37843203 http://dx.doi.org/10.4103/1673-5374.382251

Ejemplares similares

Current and future therapeutic strategies for the treatment of retinal neurodegenerative diseases
por: Maneu, Victoria, et al.
Publicado: (2021)

Current status and perspectives of conversion therapy for advanced gastric cancer
por: Yang, Heli, et al.
Publicado: (2022)

Amyotrophic lateral sclerosis, a neurodegenerative motor neuron disease with retinal involvement
por: Ramírez, Ana I., et al.
Publicado: (2021)

Rev-erbs and Glia—Implications for Neurodegenerative Diseases
por: Griffin, Percy, et al.
Publicado: (2019)

RNA Localization and Local Translation in Glia in Neurological and Neurodegenerative Diseases: Lessons from Neurons
por: Blanco-Urrejola, Maite, et al.
Publicado: (2021)

Role of Glia-Derived Extracellular Vesicles in Neurodegenerative Diseases
por: Li, Tianbai, et al.
Publicado: (2021)

Neuroprotective therapy for retinal neurodegenerative diseases by stem cell secretome
por: Usategui-Martín, Ricardo, et al.
Publicado: (2020)

A Potential Application of Glia-to-Neuron Conversion for the Treatment of Neurological Disorders
por: Liu, Sufang, et al.
Publicado: (2022)

Molecular Biomarkers of Neuronal Injury in Epilepsy Shared with Neurodegenerative Diseases
por: Negi, Deepika, et al.
Publicado: (2023)

Neurodegenerative disorders: the Glia way forward
por: Barker, Roger A., et al.
Publicado: (2014)

Dysfunctional glia: contributors to neurodegenerative disorders
por: Sidoryk-Węgrzynowicz, Marta, et al.
Publicado: (2020)

Controversy in Electromagnetic Safety
por: Chou, Chung-Kwang
Publicado: (2022)

Intestinal Permeability, Dysbiosis, Inflammation and Enteric Glia Cells: The Intestinal Etiology of Parkinson’s Disease
por: Yang, Huijia, et al.
Publicado: (2022)

Drosophila neuronal injury model allows for temporal dissection of neurodegenerative events
por: Lincoln, Barron L., et al.
Publicado: (2016)

Glial interference: impact of type I interferon in neurodegenerative diseases
por: Roy, Ethan, et al.
Publicado: (2022)

Nuclear sphingomyelin in neurodegenerative diseases
por: Albi, Elisabetta, et al.
Publicado: (2021)

Pharyngitis Management: Defining the Controversy
por: Centor, Robert Maccabee, et al.
Publicado: (2007)

Tayloring cell populations for neurodegenerative diseases
por: Fortin, Jeff M., et al.
Publicado: (2016)

Microglia-targeting nanotherapeutics for neurodegenerative diseases
por: Zhao, Nanxia, et al.
Publicado: (2020)

Significance of intercellular communication for neurodegenerative diseases
por: Cihankaya, Hilal, et al.
Publicado: (2021)

Overcoming mitochondrial dysfunction in neurodegenerative diseases
por: Pessoa, João, et al.
Publicado: (2022)

The ubiquitin proteasome system in glia and its role in neurodegenerative diseases
por: Jansen, Anne H. P., et al.
Publicado: (2014)

Leaky gut, dysbiosis, and enteric glia activation: the trilogy behind the intestinal origin of Parkinson’s disease
por: Seguella, Luisa, et al.
Publicado: (2019)

Reparative cell therapy for the heart: critical internal appraisal of the field in response to recent controversies
por: Povsic, Thomas J., et al.
Publicado: (2021)

Improving cell transplantation by understanding and manipulating the phagocytic activity of peripheral glia
por: Nazareth, Lynn, et al.
Publicado: (2021)

Inducing neuronal regeneration and differentiation via the BDNF/TrkB signaling pathway: a key target against neurodegenerative diseases?
por: Antonijevic, Mirjana, et al.
Publicado: (2023)

Insights into the protective role of immunity in neurodegenerative disease
por: Comi, Cristoforo, et al.
Publicado: (2017)

Protection against neurodegenerative disease on Earth and in space
por: Takamatsu, Yoshiki, et al.
Publicado: (2016)

Targeting mechanisms in cognitive training for neurodegenerative diseases
por: Venneri, Annalena, et al.
Publicado: (2020)

Impact of the metabolic syndrome on the evolution of neurodegenerative diseases
por: de A. Boleti, Ana Paula, et al.
Publicado: (2020)

Polyglutamine diseases: looking beyond the neurodegenerative universe
por: Mielcarek, Michal, et al.
Publicado: (2020)

Effects of Ketogenic Diet on Neuroinflammation in Neurodegenerative Diseases
por: Jiang, Ziying, et al.
Publicado: (2022)

Therapeutic potential of lysosomal cathepsins for neurodegenerative diseases
por: Prieto Huarcaya, Susy, et al.
Publicado: (2022)

Enterovirus infection and its relationship with neurodegenerative diseases
por: Sousa, Ivanildo Pedro, et al.
Publicado: (2023)

CRISPR-Mediated Induction of Neuron-Enriched Mitochondrial Proteins Boosts Direct Glia-to-Neuron Conversion
por: Russo, Gianluca L., et al.
Publicado: (2021)

CRISPR-Mediated Induction of Neuron-Enriched Mitochondrial Proteins Boosts Direct Glia-to-Neuron Conversion
por: Russo, Gianluca L., et al.
Publicado: (2021)

Critical examination of Ptbp1-mediated glia-to-neuron conversion in the mouse retina
por: Xie, Ye, et al.
Publicado: (2022)

Measuring the True Costs of War: Consensus and Controversy
por: Muggah, Robert
Publicado: (2011)

Controversy: Is Benzalkonium Chloride Necessary in Antiglaucoma Drops?
por: Louati, Y, et al.
Publicado: (2012)

Conceptualizing controversies in the EU circular bioeconomy transition
por: Starke, Jan R., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ne1e6m2qs45qknd6vqurpgh0tm